CHIR 99021, 25 mg

CHIR 99021, 25 mg

Contact us: [email protected]

CHIR 99021 trihydrochloride

B1199-5
EUR 294

CHIR-99021 (monohydrochloride)

HY-10182A 50mg
EUR 725

CHIR-99021 (trihydrochloride)

HY-10182B 50mg
EUR 725

CHIR-99021 (CT99021)

E1KS1263 2mg
EUR 325

CHIR-99021 (CT99021)

A3011-10 10 mg
EUR 171
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-100 100 mg
EUR 693
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-5 5 mg
EUR 131
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-5.1 10 mM (in 1mL DMSO)
EUR 166
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021)

A3011-S Evaluation Sample
EUR 81
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR 99021 trihydrochloride

B5779-10 10 mg
EUR 224

CHIR 99021 trihydrochloride

B5779-5 5 mg
EUR 145

CHIR-99021 (CT99021) HCl

A8396-10 10 mg
EUR 171
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-100 100 mg
EUR 693
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-5 5 mg
EUR 131
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-5.1 10 mM (in 1mL DMSO)
EUR 142
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR-99021 (CT99021) HCl

A8396-S Evaluation Sample
EUR 81
Description: CHIR-99021 is a highly specific glycogen synthase kinase-3 (GSK-3) inhibitor which can inhibit both isoforms with IC50 of 10 nM (GSK-3?) and 6.7 nM (GSK-3?).

CHIR 99021, GSK-3 Inhibitor , HCl

BC213-005 5 mg
EUR 286

CHIR 99021, GSK-3 Inhibitor , HCl

BC213-025 25 mg
EUR 847

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-002 2 mg
EUR 178

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-005 5 mg
EUR 265

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-010 10 mg
EUR 315

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-025 25 mg
EUR 394

CHIR 99021, GSK-3 Inhibitor , Free Base

BC212-100 100 mg
EUR 887

CHIR-090

B1852-25
EUR 675

CHIR-124

A8394-25 25 mg
EUR 340
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-98014

A8395-25 25 mg
EUR 374
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

Dovitinib (TKI-258, CHIR-258)

A2168-25 25 mg
EUR 224
Description: Dovitinib (TKI258, CHIR-258) is a multitargeted receptor tyrosine kinase inhibitor against FLT3, KIT, FGFR, VEGFR, PDGFR? and PDGFR? with IC50 of 1 nM, 2 nM, 8-9 nM, 8-13 nM , 210 nM and 27nM, respectively [1].

Cyanine5.5 hydrazide, 25 mg

47070 25 mg
EUR 316

Cyanine5.5 maleimide, 25 mg

47080 25 mg
EUR 316

Cyanine5.5 amine, 25 mg

470C0 25 mg
EUR 316

Cyanine3 hydrazide, 25 mg

41070 25 mg
EUR 316

Cyanine3 maleimide, 25 mg

41080 25 mg
EUR 316

Cyanine3 amine, 25 mg

410C0 25 mg
EUR 316

Alkyne hydrazide, 25 mg

41770 25 mg
EUR 101

Alkyne maleimide, 25 mg

41780 25 mg
EUR 101

Cyanine5 hydrazide, 25 mg

43070 25 mg
EUR 316

Cyanine5 maleimide, 25 mg

43080 25 mg
EUR 316

Cyanine5 amine, 25 mg

430C0 25 mg
EUR 316

Cyanine7 hydrazide, 25 mg

45070 25 mg
EUR 316

Cyanine7 maleimide, 25 mg

45080 25 mg
EUR 316

Cyanine7 amine, 25 mg

450C0 25 mg
EUR 316

Cyanine7.5 tetrazine, 25 mg

460 25 mg
EUR 513

Cyanine7.5 hydrazide, 25 mg

46070 25 mg
EUR 316

Cyanine7.5 maleimide, 25 mg

46080 25 mg
EUR 316

Cyanine7.5 amine, 25 mg

460C0 25 mg
EUR 316

Pyrene hydrazide, 25 mg

43570 25 mg
EUR 316

Pyrene maleimide, 25 mg

43580 25 mg
EUR 316

Cyanine3.5 azide, 25 mg

D2030 25 mg
EUR 316

Cyanine5 azide, 25 mg

D3030 25 mg
EUR 316

Cyanine5 alkyne, 25 mg

D30B0 25 mg
EUR 316

Cyanine5 DBCO, 25 mg

D30F0 25 mg
EUR 316

Biotin alkyne, 25 mg

D37B0 25 mg
EUR 141

Cyanine5.5 azide, 25 mg

D4030 25 mg
EUR 316

PEP azide, 25 mg

D4530 25 mg
EUR 316

Cyanine7 azide, 25 mg

D5030 25 mg
EUR 316

Cyanine7 alkyne, 25 mg

D50B0 25 mg
EUR 316

Cyanine7 DBCO, 25 mg

D50F0 25 mg
EUR 316

Perylene azide, 25 mg

D5530 25 mg
EUR 316

Cyanine7.5 azide, 25 mg

D6030 25 mg
EUR 316

Cyanine7.5 alkyne, 25 mg

D60B0 25 mg
EUR 316

Cyanine5.5 alkyne, 25 mg

D70B0 25 mg
EUR 316

Cyanine5.5 DBCO, 25 mg

D70F0 25 mg
EUR 316

Cyanine3 azide, 25 mg

D1030 25 mg
EUR 316

Cyanine3 alkyne, 25 mg

D10B0 25 mg
EUR 316

Cyanine3 DBCO, 25 mg

D10F0 25 mg
EUR 316

MG-132

1703-25
EUR 501

MG-132

A2585-25 25 mg
EUR 189
Description: MG132 (carbobenzoxy-Leu-Leu-leucinal) as a peptide aldehyde effectively blocks the proteolytic activity of proteasome complex.9 Proteasome inhibitors including MG132 have been shown to induce apoptotic cell death through formation of ROS.

MG-115

A2612-25 25 mg
EUR 282
Description: MG-115 (Z-Leu-Leu-Nva-H) is a potent, reversible peptide aldehyde inhibitor of proteasome chymotrypsin-like and caspase-like activities. It induces p53 dependent apoptosis. Blockade of proteasomal degradation by MG115 can activate autophagy.

MG 149

B3276-25 25 mg
EUR 437
Description: MG 149 is an inhibitor of histone acetyltransferases (HAT) with IC50 values of 74?M and 47?M for Tip60 and MOF, respectively [1].MG 149 is an anacardic acid derivative.

Cyanine5.5 NHS ester, 25 mg

47020 25 mg
EUR 316

Cyanine5.5 carboxylic acid, 25 mg

47090 25 mg
EUR 316

Sulfo-Cyanine5.5 maleimide, 25 mg

47380 25 mg
EUR 513

Sulfo-Cyanine5.5 amine, 25 mg

473C0 25 mg
EUR 513

BDP R6G azide, 25 mg

1476-25mg 25 mg
EUR 316

Cyanine7 dicarboxylic acid, 25 mg

1512-25mg 25 mg
EUR 316

Cyanine3 carboxylic acid, 25 mg

41090 25 mg
EUR 316

Sulfo-Cyanine3 maleimide, 25 mg

41380 25 mg
EUR 513

Sulfo-Cyanine3 amine, 25 mg

413C0 25 mg
EUR 513

sulfo-Cyanine3 DBCO, 25 mg

413F0 25 mg
EUR 513

BDP FL azide, 25 mg

41430 25 mg
EUR 316

BDP FL hydrazide, 25 mg

41470 25 mg
EUR 316

BDP FL maleimide, 25 mg

41480 25 mg
EUR 316

BDP FL amine, 25 mg

414C0 25 mg
EUR 316

AF488 NHS ester, 25 mg

41820 25 mg
EUR 513

Cyanine3.5 NHS ester, 25 mg

42020 25 mg
EUR 316

Cyanine3.5 carboxylic acid, 25 mg

42090 25 mg
EUR 316

BDP TMR azide, 25 mg

42430 25 mg
EUR 316

BDP TMR maleimide, 25 mg

42480 25 mg
EUR 316

BDP TMR amine, 25 mg

424C0 25 mg
EUR 316

Cyanine5 NHS ester, 25 mg

43020 25 mg
EUR 316

Cyanine5 carboxylic acid, 25 mg

43090 25 mg
EUR 316

Cyanine5 Boc-hydrazide, 25 mg

430A0 25 mg
EUR 316

BDP R6G tetrazine, 25 mg

444 25 mg
EUR 513

BDP R6G hydrazide, 25 mg

44470 25 mg
EUR 316

BDP R6G maleimide, 25 mg

44480 25 mg
EUR 316

BDP R6G amine, 25 mg

444C0 25 mg
EUR 316

DBCO NHS ester, 25 mg

44720 25 mg
EUR 101

Cyanine7 NHS ester, 25 mg

45020 25 mg
EUR 316

Cyanine7 carboxylic acid, 25 mg

45090 25 mg
EUR 316

Sulfo-Cyanine7 maleimide, 25 mg

45380 25 mg
EUR 513

Sulfo-Cyanine7 amine, 25 mg

453C0 25 mg
EUR 513

Cyanine7.5 NHS ester, 25 mg

46020 25 mg
EUR 316

Cyanine7.5 carboxylic acid, 25 mg

46090 25 mg
EUR 316

sulfo-Cyanine7.5 maleimide, 25 mg

46380 25 mg
EUR 513

Sulfo-Cyanine5 maleimide, 25 mg

43380 25 mg
EUR 513

Sulfo-Cyanine5 amine, 25 mg

433C0 25 mg
EUR 513

sulfo-Cyanine5 DBCO, 25 mg

433F0 25 mg
EUR 513

BDP TR azide, 25 mg

43430 25 mg
EUR 316

BDP TR hydrazide, 25 mg

43470 25 mg
EUR 316

BDP TR maleimide, 25 mg

43480 25 mg
EUR 316

BDP TR amine, 25 mg

434C0 25 mg
EUR 316

Sulfo-Cyanine3 azide, 25 mg

D1330 25 mg
EUR 513

Sulfo-Cyanine3 alkyne, 25 mg

D13B0 25 mg
EUR 513

BDP FL alkyne, 25 mg

D14B0 25 mg
EUR 316

BDP FL DBCO, 25 mg

D14F0 25 mg
EUR 316

Pyrene azide 1, 25 mg

D1530 25 mg
EUR 316

Coumarin 343 azide, 25 mg

D1630 25 mg
EUR 316

BDP TMR alkyne, 25 mg

D24B0 25 mg
EUR 316

Pyrene azide 2, 25 mg

D2530 25 mg
EUR 316

Sulfo-Cyanine5 azide, 25 mg

D3330 25 mg
EUR 513

Sulfo-Cyanine5 alkyne, 25 mg

D33B0 25 mg
EUR 513

BDP TR alkyne, 25 mg

D34B0 25 mg
EUR 316

Biotin PEG3 azide, 25 mg

D3730 25 mg
EUR 97

BDP R6G alkyne, 25 mg

D44B0 25 mg
EUR 316

BDP R6G DBCO, 25 mg

D44F0 25 mg
EUR 316

Sulfo-Cyanine7 azide, 25 mg

D5330 25 mg
EUR 513

Sulfo-Cyanine7 alkyne, 25 mg

D53B0 25 mg
EUR 513

Sulfo-Cyanine7.5 azide, 25 mg

D6330 25 mg
EUR 513

Sulfo-Cyanine7.5 alkyne, 25 mg

D63B0 25 mg
EUR 513

Sulfo-Cyanine5.5 azide, 25 mg

D7330 25 mg
EUR 513

Sulfo-Cyanine5.5 alkyne, 25 mg

D73B0 25 mg
EUR 513

CHIR-98014

2595-1
EUR 142

CHIR-98014

2595-5
EUR 414

CHIR-090

B1852-5
EUR 207

CHIR-98014

HY-13076 50mg
EUR 753

CHIR-124

HY-13263 50mg
EUR 670

CHIR-090

HY-15460 50mg
EUR 1359

CHIR-124

E1KS2683 2mg1​ PHYSICAL AND CHEMICAL PROPERTIES
EUR 325

CHIR-090

A3307-10 10 mg
EUR 382
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-200 200 mg
EUR 2716
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-5 5 mg
EUR 254
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-5.1 10 mM (in 1mL DMSO)
EUR 253
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-090

A3307-50 50 mg
EUR 1225
Description: CHIR-090 is a very potent, low, tight-binding inhibitor of LpxC with Ki value of 4.0 nM [1].LpxC is a zinc-dependent amidase and present in almost all Gram-negative bacteria.

CHIR-124

A8394-5 5 mg
EUR 151
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124

A8394-5.1 10 mM (in 1mL DMSO)
EUR 160
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-124

A8394-50 50 mg
EUR 537
Description: CHIR-124, a selective inhibitor, inhibits Chk1 with IC50 value of 0.3nM 2,000-fold more potently than Chk2 with IC50 value of 0.7?M.

CHIR-98014

A8395-10 10 mg
EUR 212
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-5 5 mg
EUR 148
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-5.1 10 mM (in 1mL DMSO)
EUR 197
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR-98014

A8395-50 50 mg
EUR 595
Description: CHIR-98014 is a potent inhibitor of GSK-3? and GSK-3? with IC50 values of 0.65 nM and 0.58 nM, respectively [1].

CHIR 99021, 25 mg